| Authors: |
Rutter CE; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT. Electronic address: charles.rutter@yale.edu., Yao X; Department of Medical Oncology, Yale School of Medicine, New Haven, CT., Mancini BR; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT., Aminawung JA; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT., Chagpar AB; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT; Department of Surgery, Yale School of Medicine, New Haven, CT., Saglam O; Department of Pathology, Yale School of Medicine, New Haven, CT., Hofstatter EW; Department of Medical Oncology, Yale School of Medicine, New Haven, CT., Abu-Khalaf M; Department of Medical Oncology, Yale School of Medicine, New Haven, CT; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT., Gross CP; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT; Department of Medicine, Yale School of Medicine, New Haven, CT., Evans SB; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT. |
